(Q77783232)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Pharmacologic treatment for children and adolescents with anxiety disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

B Birmaher

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A K Yelovich

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Renaud

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Clinics of North America

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1187-1204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

Psychotropic drugs and learning problems--a selective review

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Bleeding, a side effect of fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Extrapyramidal symptoms with selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Behavioral treatment of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

School phobia: a therapeutic trial with clomipramine and short-term outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Comparative studies of pharmacotherapy for school refusal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Childhood and adolescent depression: a review of the past 10 years. Part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Fluoxetine for childhood anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

The behavioural treatment of school refusal--a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Combined pharmacotherapy risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Assessment of the Efficacy of Buspirone in Patients Affected by Generalized Anxiety Disorder, Shifting to Buspirone From Prior Treatment with Lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Elective mutism: an analysis of 100 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Open fluoxetine treatment of mixed anxiety disorders in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Clonazepam in childhood anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Antidepressant medications and the relative risk of suicide attempt and suicide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Anxiety disorders in mid-adolescence: a community sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

A community study of anxiety in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

A preliminary analysis of a functional model of assessment and treatment for school refusal behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Depressive disorders in childhood. IV. A longitudinal study of comorbidity with and risk for anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Anxiety disorders in children and their families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

DSM-III-R anxiety disorders in children: sociodemographic and clinical characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Childhood anxiety disorders in mothers and their children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Recent developments in the psychopharmacology of anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Cognitive-behavioral psychotherapy for separation anxious children exhibiting school phobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Newer antidepressants and the cytochrome P450 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Bleeding attributed to the intake of paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Plasma levels of imipramine and metabolites in 68 hospitalized children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Chronological milestones to guide drug change. When should clinicians switch antidepressants?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Another sudden death in a child treated with desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Alprazolam effects in children with anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

7 January 2021

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Emergence of intense suicidal preoccupation during fluoxetine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Sertraline in social phobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

Comparison of cognitive therapy and relaxation training for panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970069-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70069-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884682%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference